ARADIGM CORP. ARDM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARADIGM CORP. ARDM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (189)	2/13/2004 3:37:02 PM
From: tuck	Read Replies (1) of 255

Upgrade yesterday . . . >>Punk Ziegel upgrades Aradigm Corp to Accumulate from Mkt Perform based on three factors: First, during yesterday's conference call co announced it has completed the engineering of the manufacturing process necessary to eliminate blemish from the AERx Insulin dosage packets and it has also chosen the final Intraject System configuration to bring forward into clinical verification trials. Firm believes these two announcements represent important milestones for Aradigm's drug delivery platforms. Third, believes the Pfizer, Aventis and Nektar partnership could file the Exubera regulatory application in Europe during the next several months. Punk Ziegel thinks an Exubera regulatory filing in Europe could serve as a significant catalyst for Aradigm. << Hasn't helped. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next